Full Press Release Details
BOSTON, March 03, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the following upcoming investor conferences:
43rd Annual TD Cowen Health Care Conference Orphan epilepsies panel on Monday, March 6, 2023 at 12:50 p.m. ET
Needham Neuroscience Forum Fireside chat on Wednesday, March 15, 2023 at 2:00 p.m. ET
The events will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. Replays of the webcasts will be available on Praxis’ website for at least 30 days following the events.
Contact Data
Contact
With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.